Prescott Prillaman, MD
Obstetrics & Gynecology · Richmond, VANPI 1578510780
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.0% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $417 and has fallen 89.7% since, to $43 in 2025.
Across 76 payments — averaging $18.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$235
- Amgen$109
- Astellas Pharma US Inc$105
- Therapeuticsmd, Inc.$93
- Pfizer$83
- Optumhealth Care Solutions, LLC$80
- plus $668 from 19 others
Across 132 payments — averaging $2479.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$318K
- Ferring International Pharmascience Center US$9K
What the payments were for
- Food & beverage$1,30495%
- Education$685%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $235 |
| Amgen | 6 | $109 |
| Astellas Pharma US Inc | 6 | $105 |
| Therapeuticsmd, Inc. | 6 | $93 |
| Pfizer | 6 | $83 |
| Optumhealth Care Solutions, LLC | 2 | $80 |
| Coopersurgical, Inc. | 3 | $75 |
| AMAG Pharmaceuticals, Inc. | 3 | $52 |
| Lupin Inc. | 3 | $51 |
| Novo Nordisk | 3 | $50 |
| Agile Therapeutics, Inc. | 3 | $44 |
| Duchesnay USA Incorporated | 2 | $42 |
| Myovant Sciences Inc. | 2 | $41 |
| Sumitomo Pharma America, Inc. | 2 | $41 |
| Vertical Pharmaceuticals, LLC | 3 | $39 |
| Exeltis, USA Inc. | 2 | $36 |
| Mayne Pharma Commercial LLC | 1 | $31 |
| Avion Pharmaceuticals | 2 | $29 |
| Hologic Sales And Service, LLC | 2 | $28 |
| Aspira Women's Health Inc | 1 | $23 |
| Evofem Biosciences, Inc. | 1 | $20 |
| Baxter Healthcare | 1 | $18 |
| Vertex | 1 | $18 |
| Merck | 1 | $17 |
| Bayer | 1 | $14 |
How this compares
$1,372 in reported general payments places this provider in the 70th percentile of 992 obstetrics & gynecology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 38 | $16,943 |
| Estradiol | 163 | $4,383 |
| YuvafemEstradiol | 17 | $2,759 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 12 | $1,770 |
| Estradiol (Twice Weekly)Estradiol | 16 | $1,753 |
| ProgesteroneProgesterone, Micronized | 36 | $1,550 |
| ValacyclovirValacyclovir Hcl | 28 | $738 |
| Metronidazole | 26 | $482 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 24 | $422 |
| Alendronate Sodium | 37 | $256 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 18 | $172 |
| Fluconazole | 18 | $62 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $83 | $16,94338 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 992 obstetrics & gynecology providers in Virginia.
Other obstetrics & gynecology in Richmond
- James JonesRichmond$134K
- Nicole KarjaneRichmond$34K
- Lauren SiffRichmond$16K
- Christina IsaacsRichmond$11K
- Frances CaseyRichmond$11K
- Ramzi AboujaoudeRichmond$10K
- Karen KnappRichmond$9K
- Victoria DavisRichmond$6K
- Adrienne MaraistRichmond$6K
- Thomas KimbleNorfolk$286K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.